Low Molecular Weight Inhibitors Targeting the RNA-Binding Protein HuR.

RNA pulldown assay RNA-binding protein high-throughput virtual screening human antigen R (HuR) small molecule inhibitors

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Aug 2023
Historique:
received: 31 07 2023
revised: 18 08 2023
accepted: 22 08 2023
medline: 11 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

The RNA-binding protein human antigen R (HuR) regulates stability, translation, and nucleus-to-cytoplasm shuttling of its target mRNAs. This protein has been progressively recognized as a relevant therapeutic target for several pathologies, like cancer, neurodegeneration, as well as inflammation. Inhibitors of mRNA binding to HuR might thus be beneficial against a variety of diseases. Here, we present the rational identification of structurally novel HuR inhibitors. In particular, by combining chemoinformatic approaches, high-throughput virtual screening, and RNA-protein pulldown assays, we demonstrate that the 4-(2-(2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)hydrazineyl)benzoate ligand exhibits a dose-dependent HuR inhibition effect in binding experiments. Importantly, the chemical scaffold is new with respect to the currently known HuR inhibitors, opening up a new avenue for the design of pharmaceutical agents targeting this important protein.

Identifiants

pubmed: 37685931
pii: ijms241713127
doi: 10.3390/ijms241713127
pmc: PMC10488267
pii:
doi:

Substances chimiques

Benzoates 0
RNA-Binding Proteins 0
ELAV-Like Protein 1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : German Federal Ministry of Education and Research (BMBF)
ID : 01DP19004

Références

Nucleic Acids Res. 2019 Jan 25;47(2):1011-1029
pubmed: 30418581
BMB Rep. 2009 Jan 31;42(1):41-6
pubmed: 19192392
Atherosclerosis. 2007 Nov;195(1):e134-43
pubmed: 17531241
J Comput Aided Mol Des. 2007 Dec;21(12):681-91
pubmed: 17899391
Nucleic Acids Res. 2016 Jun 2;44(10):4565-80
pubmed: 27131381
Proc Natl Acad Sci U S A. 2020 Dec 29;117(52):33204-33215
pubmed: 33376217
Trends Cardiovasc Med. 2015 Nov;25(8):684-6
pubmed: 25920625
J Biol Chem. 2017 Oct 13;292(41):16999-17010
pubmed: 28790173
Blood. 2015 May 14;125(20):3128-32
pubmed: 25838351
Int J Mol Sci. 2021 Sep 27;22(19):
pubmed: 34638733
Oncotarget. 2016 Nov 8;7(45):74043-74058
pubmed: 27677075
ACS Chem Biol. 2015 Jun 19;10(6):1476-84
pubmed: 25750985
Biochem Biophys Res Commun. 2014 May 2;447(2):371-7
pubmed: 24735540
J Nat Prod. 2020 Mar 27;83(3):770-803
pubmed: 32162523
Commun Biol. 2020 Apr 24;3(1):193
pubmed: 32332873
Wiley Interdiscip Rev RNA. 2020 May;11(3):e1581
pubmed: 31970930
J Med Chem. 2023 Feb 9;66(3):2032-2053
pubmed: 36690437
Cancer Res. 2009 Jan 15;69(2):510-7
pubmed: 19147564
Curr Opin Chem Biol. 2021 Jun;62:13-23
pubmed: 33535093
Cancer Res. 2017 May 1;77(9):2424-2438
pubmed: 28428272
J Neurosci. 2007 Jul 25;27(30):7929-38
pubmed: 17652584
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
J Cell Physiol. 2003 Jun;195(3):356-72
pubmed: 12704645
Cancer Biol Ther. 2022 Dec 31;23(1):139-149
pubmed: 35130122
Genes Dev. 1999 Feb 15;13(4):449-61
pubmed: 10049360
J Chem Theory Comput. 2016 Jan 12;12(1):281-96
pubmed: 26584231
J Neurochem. 2009 Feb;108(4):1032-44
pubmed: 19196430
Exp Mol Med. 2009 Nov 30;41(11):824-31
pubmed: 19949288
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
J Clin Invest. 2001 Dec;108(11):1657-65
pubmed: 11733561
PLoS Comput Biol. 2017 Jun 29;13(6):e1005522
pubmed: 28662117
Nat Chem Biol. 2007 Aug;3(8):508-15
pubmed: 17632515
Nucleic Acids Res. 2015 Jul 1;43(W1):W612-20
pubmed: 25883136
Mol Cancer Ther. 2014 May;13(5):1206-16
pubmed: 24651526
J Cheminform. 2015 May 20;7:20
pubmed: 26052348
Biochem Biophys Res Commun. 2011 Dec 9;416(1-2):99-105
pubmed: 22093832
Nature. 2023 Apr;616(7958):673-685
pubmed: 37100941
Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):2935-2944
pubmed: 30718402
Nature. 1990 Dec 6;348(6301):515-20
pubmed: 2147232
ACS Med Chem Lett. 2019 Jan 21;10(4):615-620
pubmed: 30996806
Front Immunol. 2022 May 26;13:923647
pubmed: 35711457
Exp Cell Res. 2015 Jan 1;330(1):66-80
pubmed: 25240929
Wiley Interdiscip Rev RNA. 2017 Jan;8(1):
pubmed: 27307117
Biochem Biophys Res Commun. 2000 Jan 27;267(3):726-32
pubmed: 10673359
J Biol Chem. 2003 Sep 19;278(38):36157-62
pubmed: 12855701
Nat Rev Chem. 2020 Sep;4(9):441-458
pubmed: 37127961
Sci Rep. 2018 Sep 13;8(1):13780
pubmed: 30214075
Nucleic Acids Res. 2019 Jan 8;47(D1):D930-D940
pubmed: 30398643
Front Mol Biosci. 2021 Apr 27;8:658852
pubmed: 33987205
PLoS One. 2015 Sep 21;10(9):e0138780
pubmed: 26390015
Cancer Biol Ther. 2008 Sep;7(9):1496-506
pubmed: 18769129
BMC Bioinformatics. 2018 Mar 9;19(1):91
pubmed: 29523085
Nucleic Acids Res. 2019 Jul 2;47(W1):W357-W364
pubmed: 31106366
Acta Crystallogr D Biol Crystallogr. 2013 Mar;69(Pt 3):373-80
pubmed: 23519412
Mol Biol Cell. 2007 Jun;18(6):2137-48
pubmed: 17392515
J Comput Aided Mol Des. 2010 Jun;24(6-7):591-604
pubmed: 20354892
Mol Cancer Ther. 2013 Jul;12(7):1202-12
pubmed: 23619299
PLoS One. 2013 Aug 12;8(8):e72426
pubmed: 23951323
Neurobiol Pain. 2018 Aug-Dec;4:2-7
pubmed: 30370343
PLoS One. 2017 Apr 17;12(4):e0175471
pubmed: 28414767
Cell Death Discov. 2023 Feb 9;9(1):52
pubmed: 36759501
J Med Chem. 2018 Feb 22;61(4):1483-1498
pubmed: 29313684
Cancer Med. 2018 Dec;7(12):6269-6280
pubmed: 30449075
Nucleic Acids Res. 2017 Sep 19;45(16):9514-9527
pubmed: 28934484
J Med Chem. 2017 Oct 26;60(20):8257-8267
pubmed: 28587461
Wiley Interdiscip Rev RNA. 2010 Sep-Oct;1(2):214-29
pubmed: 21935886
J Biol Chem. 2003 Jul 4;278(27):25227-33
pubmed: 12704185
Nucleic Acids Res. 2015 Jul 1;43(W1):W443-7
pubmed: 25873628
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15293-8
pubmed: 9860962
FEBS Lett. 2008 Jun 18;582(14):1977-86
pubmed: 18342629
J Chem Inf Model. 2021 Feb 22;61(2):699-714
pubmed: 33494610
Sci Rep. 2015 Nov 10;5:16478
pubmed: 26553968
J Neurosci. 2022 Dec 7;42(49):9129-9141
pubmed: 36270801

Auteurs

Benjamin Philipp Joseph (BP)

Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany.
Faculty of Mathematics, Computer Science and Natural Sciences, RWTH Aachen University, 52062 Aachen, Germany.

Verena Weber (V)

Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany.
Faculty of Mathematics, Computer Science and Natural Sciences, RWTH Aachen University, 52062 Aachen, Germany.

Lisa Knüpfer (L)

Institute of Biology, University of Siegen, 57076 Siegen, Germany.

Alejandro Giorgetti (A)

Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany.
Department of Biotechnology, University of Verona, 37134 Verona, Italy.

Mercedes Alfonso-Prieto (M)

Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany.

Sybille Krauß (S)

Institute of Biology, University of Siegen, 57076 Siegen, Germany.

Paolo Carloni (P)

Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany.
Faculty of Mathematics, Computer Science and Natural Sciences, RWTH Aachen University, 52062 Aachen, Germany.

Giulia Rossetti (G)

Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany.
Jülich Supercomputing Centre (JSC), Forschungszentrum Jülich, 52425 Jülich, Germany.
Department of Neurology, RWTH Aachen University, 44517 Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH